The Effect of an AI-Powered, Interactive Learning Tool on Knowledge of Infection Control

November 13, 2026 updated by: Bilecik Seyh Edebali Universitesi

The Effect of an Artificial Intelligence-Supported Clinical Case Simulation and an Interactive Learning Tool on Nursing Students' Infection Control Knowledge, Motivation, and Self-Efficacy: A Randomized Controlled Trial

Practical exercises will be conducted using an AI-supported, interactive learning tool to enhance nursing students' knowledge of infection control and improve their learning skills.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This study aims to investigate the impact of an AI-supported clinical case simulation and interactive learning tool on nursing students' knowledge of infection control, motivation, and self-efficacy. The study is unique in its integration of AI-supported clinical case simulation and interactive learning within the context of infection control. Interactive methods will be incorporated into training on hand hygiene, the use of personal protective equipment, isolation protocols, and cross-contamination. It is anticipated that the study will make a significant contribution to the literature and serve as a guide for educators.

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 60 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Receiving information on infection control for the first time
  • Participating in the final test and follow-up test

Exclusion Criteria:

  • Having previously received training in infection control
  • Failure to participate in the most recent test and follow-up test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The Effect of an AI-Powered, Interactive Learning Tool on Knowledge Levels

Changes in Students' Knowledge Levels

Interactive education for nursing students

Experimental: The Effect of an AI-Powered, Interactive Learning Tool on Students' Self-Directed Learning Skills

The Effect of an AI-Powered, Interactive Learning Tool on Students' Self-Directed Learning Skills

Interactive education for nursing students

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of pre-test, post-test, and follow-up test results
Time Frame: 6 week

Knowledge Levels

6 week
Self-Directed Learning Skills
Time Frame: 5 week

Brief and Universal Self-Efficacy Scale for Clinical Skills

5 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Aysun Acun, Ph.D., Bilecik Seyh Edebali Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 15, 2026

Study Registration Dates

First Submitted

October 20, 2026

First Submitted That Met QC Criteria

November 13, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Aysun Acun 15

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.